All posts

AcuityAds gets “Top Pick” status at Echelon Wealth Partners

AcuityAds CEO Tal Hayek.
Continued momentum at AcuityAds Holdings (AcuityAds Stock Quote, Chart: TSXV:AT) has Echelon Wealth Partners analyst Rob Goff adding the stock to the firm’s “Top Pick Portfolio” and raising his price target on the stock.

In a research report to clients Wednesday, Goff maintained his “Speculative Buy” rating, but raised his one-year price target on AcuityAds from $1.40 to $1.80, implying a return of 59 per cent at the time of publication.

Goff explained some of the reasoning behind his increased bullishness.

“We retain our longstanding positive view towards AT’s programmatic platform,” the analyst explained. “We look for building momentum with y/y organic growth beyond Q318 no longer hurt by the EMEA self-service business terminated by AT or by the 140 Proof client taking in house (announced Sept. 11/17). Visible organic growth together with the accretion associated with the ADman acquisition (closed June 15/18) and the Sept. 10/18 strategic transaction to acquire sales professionals and specific assets from a US artificial intelligence company. The most recent acquisition was negotiated for no upfront investment brought roughly 20 established sales professionals where incremental sales could approach $20M annually. The most recent deal included a six month earnout based on a set percentage of net revenues. It is expected that the earnout should be roughly in line with the positive net working capital of the acquisition.”

Goff’s upwardly revised figures for fiscal 2018 have AT generating Adjusted EBITDA of $600,000 on revenue of $58.7-million.

“Our Top Pick Portfolio constituents typically reflect positive catalyst potential,” the analyst adds. “We prefer to avoid turnarounds. However, we are adding AT to our Top Pick Portfolio given its near term financial momentum and the potential for positive forecast and in turn valuation revisions.”

Tagged with: at
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Tilray price target chopped at Roth Capital

Roth Capital Markets analyst Bill Kirk said in a July 30 note that Tilray’s (Tilray Stock Quote, Chart, News, Analysts,… [Read More]

12 minutes ago

Bitcoin Treasury Corporation is a buy, Research Capital says

Research Capital analyst Greg McLeish initiated coverage of Bitcoin Treasury Corporation (Bitcoin Treasury Corporation Stock Quote, Chart, News, Analysts, Financials… [Read More]

18 minutes ago

Cannara Biotech is a buy, Research Capital says

Research Capital analyst Greg McLeish said in a July 29 update that Cannara Biotech (Cannara Biotech Stock Quote, Chart, News,… [Read More]

23 hours ago

Ahead of Q2 results, is Tantalus Systems a buy?

Beacon Securities analyst Gabriel Leung noted in a July 30 report that Tantalus Systems (Tantalus Systems Holding Stock Quote, Chart,… [Read More]

23 hours ago

Sanuwave Health is a buy, Roth Capital says

Roth Capital Markets is initiating coverage of Sanuwave Health (Sanuwave Health Stock Quote, Chart, News, Analysts, Financials NASDAQ:SNWV) with a… [Read More]

24 hours ago

Shoulder Innovations is an IPO to watch, this analyst says

Roth Capital Markets analyst Jason Wittes noted in a July 28 pre-IPO report that Shoulder Innovations, a new entrant in… [Read More]

24 hours ago